Metabolic syndrome is associated with poor memory and executive performance in elderly community residents: The PROOF study

American Journal of Geriatric Psychiatry

Volumn 22, Issue 11, 2014, Pages 1096-1104

  Rouch, Isabelle ^a,b   Trombert, Béatrice ^a,c   Kossowsky, Michel P ^d   Laurent, Bernard ^a   Celle, Sébastien ^a,c   Ntougou Assoumou, Gabin ^c   Roche, Frédéric ^a,c   Barthelemy, Jean Claude ^a,c  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b Hopital des Charpennes CHU de Lyon   (France)

^c Jean Monnet University of Saint Étienne   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

cognitive impairment; elderly; Metabolic syndrome

Indexed keywords

AGED; ARTICLE; CROSS-SECTIONAL STUDY; DEMENTIA; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DETERIORATION; METABOLIC SYNDROME X; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; SEX DIFFERENCE; BLOOD; COMPLICATION; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MEMORY DISORDERS; PSYCHOLOGY; RISK FACTOR;

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; MEMORY DISORDERS; METABOLIC SYNDROME X; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84927974074     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2014.01.005     Document Type: Article

References (66)

1. Watts AS, Loskutova N, Burns JM, et al: Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults. J Alzheimers Dis 2013; 35:253-265
2. Kopf D, Frolich L: Risk of incident Alzheimer's disease in diabetic patients: A systematic review of prospective trials. J Alzheimers Dis 2009; 16:677-685
3. Maher PA, Schubert DR: Metabolic links between diabetes and Alzheimer's disease. Expert Rev Neurother 2009; 9:617-630
4. Sato N, Morishita R: Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: Short-and longterm modification by non-genetic risk factors. Front Aging Neurosci 2013; 5:64
5. ReitzC,TangMX, Schupf N, et al:Associationof higher levelsof highdensity lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol 2010; 67:1491-1497
6. Stewart R, White LR, Xue QL, et al: Twenty-six-year change in total cholesterol levels and incident dementia: The Honolulu-Asia Aging Study. Arch Neurol 2007; 64:103-107
7. Skoog I, Lernfelt B, Landahl S, et al: 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-1145
8. Launer LJ, Ross GW, Petrovitch H, et al: Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 2000; 21:49-55
9. Kivipelto M, Helkala EL, Hanninen T, et al: Midlife vascular risk factors and late-life mild cognitive impairment: A populationbased study. Neurology 2001; 56:1683-1689
10. Takeda S, Sato N, Ogihara T, et al: The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: New therapeutic potential. Front Biosci 2008; 13:2253-2265
11. Forette F, Seux ML, Staessen JA, et al: The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002; 162:2046-2052
12. Curb JD, Rodriguez BL, Abbott RD, et al: Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 1999; 52:971-975
13. Reitz C, Tang MX, Luchsinger J, et al: Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004; 61: 705-714
14. Verghese J, Lipton RB, Hall CB, et al: Low blood pressure and the risk of dementia in very old individuals. Neurology 2003; 61: 1667-1672
15. Selkoe DJ: Preventing Alzheimer's disease. Science 2012; 337: 1488-1492
16. NCEP: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497
17. Cukierman-Yaffe T, Gerstein HC, Williamson JD, et al: Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: The action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 2009; 32:221-226
18. Williamson R, McNeilly A, Sutherland C: Insulin resistance in the brain: An old-age or new-age problem? Biochem Pharmacol 2012; 84:737-745
19. Bourdel-Marchasson I, Lapre E, Laksir H, et al: Insulin resistance, diabetes and cognitive function: Consequences for preventative strategies. Diabetes Metab 2010; 36:173-181
20. Cukierman T, Gerstein HC, Williamson JD: Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005; 48:2460-2469
21. Van Den Berg E, Reijmer YD, De Bresser J, et al: A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 2010; 53:58-65
22. Frisardi V, Solfrizzi V, Seripa D, et al: Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 2010; 9:399-417
23. Duron E, Hanon O: Hypertension, cognitive decline and dementia. Arch Cardiovasc Dis 2008; 101:181-189
24. Van Vliet P: Cholesterol and late-life cognitive decline. J Alzheimers Dis 2012; 30(Suppl 2):S147eS162
25. Gustafson D: Adiposity indices and dementia. Lancet Neurol 2006; 5:713-720
26. Yaffe K, Kanaya A, Lindquist K, et al: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242
27. Dik MG, Jonker C, Comijs HC, et al: Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007; 30:2655-2660
28. Komulainen P, Lakka TA, Kivipelto M, et al: Metabolic syndrome and cognitive function: A population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 2007; 23:29-34
29. Van Den Berg E, Biessels GJ, De Craen AJ, et al: The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 2007; 69:979-985
30. Ho RC, Niti M, Yap KB, et al: Metabolic syndrome and cognitive decline in Chinese older adults: Results from the Singapore longitudinal ageing studies. Am J Geriatr Psychiatry 2008; 16: 519-522
31. Yaffe K, Weston AL, Blackwell T, et al: The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009; 66:324-328
32. Solfrizzi V, Scafato E, Capurso C, et al: Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging 2009; 32:1932-1941
33. Roberts RO, Geda YE, Knopman DS, et al: Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: A population-based study. Alzheimer Dis Assoc Disord 2010; 24:11-18
34. Tournoy J, Lee DM, Pendleton N, et al: Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: The European Male Ageing Study. Diabetes Metab Res Rev 2010; 26:668-676
35. Lee KS, Eom JS, Cheong HK, et al: Effects of head circumference and metabolic syndrome on cognitive decline. Gerontology 2009; 56:32-38
36. Lee KS, Jang Y, Chung YK, et al: Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly. Arch Gerontol Geriatr 2010; 50:69-72
37. Reijmer YD, Van Den Berg E, Dekker JM, et al: The metabolic syndrome, atherosclerosis and cognitive functioning in a nondemented population: The Hoorn Study. Atherosclerosis 2011; 219:839-845
38. Laudisio A, Marzetti E, Pagano F, et al: Association of metabolic syndrome with cognitive function: The role of sex and age. Clin Nutr 2008; 27:747-754
39. Barthelemy JC, Pichot V, Dauphinot V, et al: Autonomic nervous system activity and decline as prognostic indicators of cardiovascular and cerebrovascular events: The ?PROOF' Study. Study design and population sample. Associations with sleep-related breathing disorders: The ?SYNAPSE' Study. Neuroepidemiology 2007; 29:18-28
40. Juonala M, Viikari JS, Hutri-Kahonen N, et al: The 21-year followup of the Cardiovascular Risk in Young Finns Study: Risk factor levels, secular trends and east-west difference. J Intern Med 2004; 255:457-468
41. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502
42. Grober E, Buschke H: Genuine memory deficits in dementia. Dev Neuropsychol 1987; 3:13-36
43. Van Der Linden M, Adam S, Agniel A, et al: L0évaluation des troubles De lamémoire. Présentation De quatre tests demémoireépisodique (avec leurétalonnage). Marseille, France: Editions Solal, 2004
44. Wechsler D. Manuel De l'échelle d'intelligence De Wechsler pour Adultes (WAIS III). Paris: Editions du centre De psychologie appliquée, 2000
45. Thomas SA, Lincoln NB: Depression and cognitions after stroke: Validation of the Stroke Cognitions Questionnaire Revised (SCQR). Disabil Rehabil 2008; 30:1779-1785
46. Reitan RM: Manual for administration of neuropsychological test batteries for adults and children. Tucson, AZ, Reitan Neuropsychology Laboratories Inc.,1979
47. Baddeley A, Della Sala S, Papagno C, et al: Dual-task performance in dysexecutive and nondysexecutive patients with a frontal lesion. Neuropsychology 1997; 11:187-194
48. Stroop J: Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18:643-662
49. Cardebat D, Doyon B, Puel M, et al: Evocation lexicale formelle et sémantique chez des sujets normaux: Performances et dynamique De production en fonction du sexe, De l'âge et du niveau d'études. Acta Neurologica Belgica 1990; 90:207-217
50. Pichot P, Brun JP: [Brief self-evaluation questionnaire for depressive, asthenic and anxious dimensions]. Ann Med Psychol (Paris) 1984; 142:862-865
51. Goldberg D, Bridges K, Duncan-Jones P, et al: Detecting anxiety and depression in general medical settings. BMJ 1988; 297: 897-899
52. Denys K, Cankurtaran M, Janssens W, et al: Metabolic syndrome in the elderly: An overview of the evidence. Acta Clin Belg 2009; 64:23-34
53. Akbaraly TN, Kivimaki M, Shipley MJ, et al: Metabolic syndrome over 10 years and cognitive functioning in late midlife: The Whitehall II study. Diabetes Care 2010; 33:84-89
54. Cavalieri M, Ropele S, Petrovic K, et al: Metabolic syndrome, brain magnetic resonance imaging, and cognition. Diabetes Care 2010; 33:2489-2495
55. Schuur M, Henneman P, Van Swieten JC, et al: Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol 2010; 25: 561-568
56. Creavin ST, Gallacher J, Bayer A, et al: Metabolic syndrome, diabetes, poor cognition, and dementia in the Caerphilly prospective study. J Alzheimers Dis 2012; 28:931-939
57. Segura B, Jurado MA, Freixenet N, et al: White matter fractional anisotropy is related to processing speed in metabolic syndrome patients: A case-control study. BMC Neurol 2010; 10:64
58. Frisardi V, Solfrizzi V, Imbimbo PB, et al: Towards diseasemodifying treatment of Alzheimer's disease: Drugs targeting beta-amyloid. Curr Alzheimer Res 2009; 7:40-55
59. Portet F, Brickman AM, Stern Y, et al: Metabolic syndrome and localization of white matter hyperintensities in the elderly population. Alzheimers Dement 2012; 8(5 Suppl): S88eS95, e1
60. Palmer AM: Pharmacotherapy for Alzheimer's disease: Progress and prospects. Trends Pharmacol Sci 2002; 23:426-433
61. Ferri CP, Prince M, Brayne C, et al: Global prevalence of dementia: A Delphi consensus study. Lancet 2005; 366: 2112-2117
62. Kalmijn S, Feskens EJ, Launer LJ, et al: Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995; 38:1096-1102
63. Roriz-Cruz M, Rosset I, Wada T, et al: Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population. Neurobiol Aging 2007; 28:1723-1736
64. Raffaitin C, Gin H, Empana JP, et al: Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: The Three-City Study. Diabetes Care 2009; 32:169-174
65. Solfrizzi V, Scafato E, Capurso C, et al: Metabolic syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry 2010; 81:433-440
66. Solfrizzi V, Scafato E, Capurso C, et al: Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging 2011; 32: 1932-1941